Form 4: FMR LLC Reports Metsera Stock Transactions

FMR LLC and its affiliated entities reported a series of transactions involving Metsera, Inc. common stock, including distributions without consideration and a small sale.

Summary

• FMR LLC, identified as a 10% owner of Metsera, Inc. (MTSR), filed a Form 4 detailing changes in beneficial ownership.
• The earliest transaction date reported is November 3, 2025.
• Transactions involved several FMR LLC affiliated entities: F-Prime Capital Partners Life Sciences Fund VIII LP, F-Prime Capital Partners Life Sciences Advisors Fund VIII LP, F-Prime Inc., and Impresa Fund IV LLC.
• Most transactions (coded 'J') represent acquisitions or dispositions of common stock in the form of distributions without payment of consideration.
• One transaction (coded 'S') involved Impresa Fund IV LLC disposing of 193 shares of Metsera Common Stock at a price of $61.2281 per share.
• Following these transactions, the beneficial ownership of Metsera Common Stock by various indirect entities changed, with some entities showing 0 shares and others holding millions of shares indirectly.

Sentiment

Score: 5

Explanation: The filing is largely neutral, reporting routine insider transactions, primarily distributions without consideration, and a very small sale. It does not provide information that would significantly alter the investment thesis for Metsera, Inc.

Positives

• FMR LLC, through its various entities, continues to hold a significant stake in Metsera, Inc., indicating ongoing investment interest.
• The majority of reported transactions are distributions without consideration, rather than open market sales, suggesting a restructuring of holdings rather than a divestment strategy.

Negatives

• Impresa Fund IV LLC sold 193 shares of Metsera Common Stock at $61.2281 per share, representing a small insider sale.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding Metsera, Inc.'s future performance or strategic direction.

Management Comments

• "These holdings were acquired or disposed of (as applicable) in the form of a distribution without payment of consideration."
• "The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the undersigned are the beneficial owners of any securities reported herein."

Industry Context

Form 4 filings are standard regulatory disclosures for insiders reporting changes in their beneficial ownership. FMR LLC, a major financial services firm, frequently makes such filings through its various investment arms, particularly in the life sciences sector where its F-Prime and Impresa funds are active. These transactions reflect routine adjustments in portfolio holdings or internal distributions within a large investment group.

Management Changes

Corporate Governance

Related Party Transactions

• The reported transactions involve FMR LLC and its direct and indirect subsidiaries (F-Prime Capital Partners Life Sciences Fund VIII LP, F-Prime Capital Partners Life Sciences Advisors Fund VIII LP, F-Prime Inc., Impresa Fund IV LLC), which are all related entities.
• Many transactions are described as distributions without payment of consideration, indicating internal transfers or reallocations of holdings among related parties.
• The filing explicitly details the ownership and management relationships between FMR LLC, the Johnson family, and the various F-Prime and Impresa funds, highlighting the related-party nature of the beneficial ownership.

Stakeholder Impact

• Shareholders of Metsera, Inc. may note the continued significant indirect ownership by FMR LLC and its affiliates, which could be viewed as a long-term commitment.
• The small insider sale by Impresa Fund IV LLC is unlikely to have a material impact on the broader market sentiment or share price.

Key Dates

Keywords

Metsera, MTSR, FMR LLC, F-Prime Capital, Impresa Fund, Insider Transaction, Beneficial Ownership, SEC Form 4, Stock Distribution